Loading data for NVZMY — first visit, this takes a few seconds.

Novozymes A/S

OTC Markets OTCPK: NVZMY · Real-Time Price · USD
65.80
-1.37 (-2.04%)
At close: Sep 11, 2026, 6:33 PM

The price, the headline numbers and the latest news, in one place.

Novozymes A/S (NVZMY) Stock Price, Analysis & Data

No data available

Bid65.6
Market Cap30.9B
Revenue (ttm)4.3B
Net Income (ttm)632M
0.63
1.58
41.98
24.26
P/B (ttm)2.39
P/S (ttm)7.20
Earnings DateFeb 24, 2027
Ask65.84
Volume1,200
Avg. Volume (20D)30,883
Open66.01
Previous Close67.17
Day's Range65.70 - 66.01
52-Week Range49.90 - 75.27
Analystn/a
Price Targetn/a
Dividends$1.02 (1.51%)
Ex-Dividend DateAug 31, 2026

About NVZMY

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including bi...

IPO Date Jan 20, 2010
Employees 10,933
Stock Exchange OTC Markets OTCPK
Ticker Symbol NVZMY
Full Company Profile

Financial Performance

In 2025, Novozymes A/S's revenue was 4.16B, an increase of 8.45% compared to the previous year's 3.83B. Earnings were 583.6M, an increase of 90.84%.

Financial Statements

Earnings Surprise

Novozymes A/S has released their quarterly earnings on Feb 1, 2024:
  • Revenue of $1.12B misses estimates by $0, with 3.58% YoY growth.
  • EPS of 0.44 misses estimates by 0.00, with -8.33% YoY decline.
Novozymes A/S is scheduled to release its earnings on Feb 24, 2027, before market opens.
Analysts project revenue of ... Upgrade